Updated Guidelines for Preventing Osteoporosis-Related Fractures Released
By Dennis Thompson HealthDay Reporter
TUESDAY, Jan. 14, 2025 -- All women 65 and older should continue to be screened for osteoporosis, the nation’s leading preventive health panel says in an updated recommendation.
The U.S. Preventive Services Task Force also recommends screening women younger than 65 who’ve gone through menopause and are at increased risk of a fracture from bone loss, according to the updated guidelines published in the Journal of the American Medical Association.
“Too often, the first sign of osteoporosis is a broken bone, which can lead to serious health issues,” USPSTF member Dr. Esa Davis said in a statement from the group.
“The good news is that for women 65 years or older, as well as younger women at increased risk, screening can detect osteoporosis early—before fractures happen—helping women maintain their health, independence, and quality of life,” added Davis, senior associate dean of population and community medicine at the University of Maryland School of Medicine.
Osteoporosis happens as people grow older and their bones lose the ability to regrow and replenish themselves.
As bones become thinner and less dense, the risk of a bone fracture grows worse. Bones most commonly broken due to osteoporosis include the hips, wrists and spine, according to the Cleveland Clinic.
The updated guideline for women is consistent with earlier versions issued in 2018 and 2011. The USPSTF regularly reviews each of its screening guidelines, to make sure that they adhere to the most recent findings from medical science.
There’s still not enough evidence to say whether or not osteoporosis screening would be beneficial for men, the USPSTF guideline also says.
“While screening can identify men who have osteoporosis, we need more evidence on whether or not screening and current treatments prevent fractures in men,” USPSTF vice chair Dr. John Wong said in a news release.
“The Task Force continues to call for more research in men and encourages anyone concerned about their bone health to speak with their clinician,” added Wong, chief of the Tufts Medical Center Division of Clinical Decision Making.
There also are important health inequities related to osteoporosis screening, the task force added. Risk assessment tools have some limitations in predicting fracture risk for Black, Hispanic and Asian people.
“It is important that clinicians be aware of these limitations,” the task force said in its statement. ”Clinicians may also want to consider additional risk factors to help inform discussions with their patients and determine whether screening or treatment for osteoporosis is needed.”
The USPSTF is an independent volunteer panel of national experts in preventive medicine.
However, the group’s guidelines can make a huge difference in health care coverage. The Affordable Care Act requires that any screenings recommended by the USPSTF be covered free of charge.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-15 06:00
Read more
- Can Carrots Help Treat Type 2 Diabetes?
- Will We Have Fewer Doctors of Color?
- Gestational Exposure to NSAIDs Tied to Childhood Chronic Kidney Disease
- Tragic Pet Cat Deaths Linked to Bird Flu in Raw Milk
- AI Proves Useful for Ovarian Cancer Diagnosis
- Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions